Review of the Pathways Involved in the Osteogenic Differentiation of Adipose-Derived Stem Cells. by Asserson, Derek B et al.
UC Davis
UC Davis Previously Published Works
Title
Review of the Pathways Involved in the Osteogenic Differentiation of Adipose-Derived Stem Cells.
Permalink
https://escholarship.org/uc/item/8b876731
Journal
The Journal of craniofacial surgery, 30(3)
ISSN
1049-2275
Authors
Asserson, Derek B
Orbay, Hakan
Sahar, David E
Publication Date
2019-05-01
DOI
10.1097/scs.0000000000005447
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
ORIGINAL ARTICLEReview of the Pathways Involved in the Osteogenic
Differentiation of Adipose-Derived Stem Cells
Derek B. Asserson, BS, Hakan Orbay, MD, PhD, and David E. Sahar, MDCopyright © 2019 Mutaz B. Habal, MD. Unauthorized reproducti
From the Department of Surgery, Surgical Bioengineering Laboratory,
University of California Davis Medical Center, Sacramento, CA.
Received November 2, 2018.
Accepted for publication February 4, 2019.
Address correspondence and reprint requests to Hakan Orbay, MD, PhD,
4625 2nd Avenue, Research Building II, Room 3004 Sacramento, CA
95817; E-mail: hakanorbay78@hotmail.com; Derek B. Asserson, BS,
University of California Davis, Sacramento, CA;
E-mail: derek.asserson2615@cnsu.edu
The authors report no conflicts of interest.
Copyright # 2019 by Mutaz B. Habal, MD
ISSN: 1049-2275
DOI: 10.1097/SCS.0000000000005447
The Journal of Craniofacial Surgery  Volume 30, Number 3, May 2019Abstract:Grafts and prosthetic materials used for the repair of bone
defects are often accompanied by comorbidity and rejection.
Therefore, there is an immense need for novel approaches to
combating the issues surrounding such defects. Because of their
accessibility, substantial proportion, and osteogenic differentiation
potential, adipose-derived stem cells (ASCs) make for an ideal
source of bone tissue in regenerative medicine. However, efficient
induction of ASCs toward an osteoblastic lineage in vivo is met with
challenges, and many signaling pathways must come together to
secure osteoblastogenesis. Among them are bone morphogenic
protein, wingless-related integration site protein, Notch, Hedgehog,
fibroblast growth factor, vascular endothelial growth factor, and
extracellular regulated-signal kinase. The goal of this literature
review is to conglomerate the present research on these pathways to
formulate a better understanding of how ASCs are most effectively
transformed into bone in the context of tissue engineering.
Key Words: Adipose-derived stem cells, bone regeneration,
osteogenic differentiation, tissue engineering
(J Craniofac Surg 2019;30: 703–708)
n 2001, 12,700 bone grafts were performed to repair craniofacial
1I defects at a cost of over $549 million in children alone. Another
1.3–1.5 million grafts were constructed in 2010 to fix defects of the
cranium, sternum, ribs, and extremities.2 It is said that bone grafting
is also required in 1 out of every 4 dental implants.3 This reach
seems to be a transnational occurrence, as graft materials are
approved all over the world, with some countries placing great
importance on the procedures in training programs.2,4
Current treatment methods using autologous bone, allogenic
transplants, and prosthetic materials all carry significant drawbacks,
such as donor-site morbidity, immune rejection, and extrusion and
infection, while failing to meet the enormous and ever-increasing
demand for reconstruction of skeletal deficiencies.5 This gap has
provided impetus to develop regenerative medicine that is being
relied on more often to deal with disease and trauma. Engineering
bone tissue was only made possible with the discovery and utiliza-
tion of stem cells that are capable of self-renewal and differentiationinto a bevy of lineages.6 The implementation of stem cells for the
purpose of bone regeneration potentially eliminates the afore-
mentioned problems associated with autologous and allogenic
grafts.5
Because of their high differentiation potential and lowmorbidity
during harvesting, bone marrow stem cells (BMSCs) have been
considered the gold standard in bone tissue engineering.7–9 How-
ever, low cellular yields, as well as extremely painful extraction,
have pushed research in a novel direction, one that places fat at the
core of regenerative medicine.10–13 Adipose-derived stem cells
(ASCs) have similar transcription profiles to BMSCs for genes
induced in stem-cell phenotypes, and are identified for their ability
to differentiate into a vast array of lineages, including adipogenic,
chondrogenic, myogenic, neurogenic, and osteogenic forms.14,15
Roughly 5000 fibroblast colony-forming units (CFU-F) are
obtained per gram of adipose tissue, and ASCs constitute 2% of
the nucleated cells in processed lipoaspirate.16 Compared with
only 100 to 1000 CFU-F per milliliter of bone marrow, adipose
tissue makes for an excellent source of mesenchymal stem cells
(MSCs).16
Secondary to ASC harvesting, scaffolds are employed to
ensure proper behavior of the stem cells by generating controlled
niches and delivering appropriate biomaterials.17–19 Optimal
bone regeneration is achieved with certain physical and biological
characteristics of the scaffold, especially cell attachment sites, in
which the ideal osteogenic scaffold is a porous, biodegradable,
three-dimensional structure.20–23 The culture medium of ASCs
also largely helps determine differentiation potential toward
certain lineages.24
Although several papers demonstrate the osteogenic differenti-
ation of ASCs, the molecular mechanisms by which the ASCs
differentiate into osteoprogenitor cells are not as easily understood
and no systematic review of them exists in the literature. This
review serves to elucidate those mechanisms through research
endeavors that have successfully turned ASCs into bone. The
pertinent papers are classified according to main signaling path-
ways in Table 1.
METHODS
A search of the PubMed/Medline database was performed with the
search terms ‘‘adipose-derived stem cells’’ OR ‘‘ASCs’’ AND
‘‘osteogenic differentiation.’’ Initial results yielded 256 papers,
which was reduced to 179 after title screening. When subsequently
screened for content, 14 backgrounds (some of which were not
used) and 29 experimental papers were left. An additional 62
investigations found via connected articles were incorporated to
further substantiate the literature review.
RESULTS
Osteoblastogenesis or osteoblast differentiation during develop-
ment is controlled by a complex network at both the transcriptional
level and extracellular signaling pathways.5 The key players in the
transcriptional control of osteoblast differentiation are Runt-related
family 2 (RUNX2), formerly called Cbfa1,25–29 and the lateon of this article is prohibited.
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TABLE 1. Classification of Signaling Pathways by Paper
Author Year Signaling Pathway
Arnsford et al 2009 Wnt
Bandyopadhyay et al 2006 BMP
Behr et al 2012 VEGF
Bergwitz et al 2001 Wnt
Boyden et al 2002 Wnt
Burke et al 1998 FGF
Cadigan et al 1997 Wnt
Chang et al 2007 Wnt
Chen et al 2004 BMP
Chillakuri et al 2012 Notch
Cowan et al 2004 BMP
Daluiski et al 2001 BMP
Deregowski et al 2006 Notch
Ding et al 2014 VEGF
Dragoo et al 2003 BMP
Dragoo et al 2005 BMP
Eswarakumar et al 2002 FGF
Fan et al 2016 Notch
Fan et al 2013 BMP
Fan et al 2014 BMP
Fan et al 2016 BMP
Fischer et al 2002 Wnt
Gilboa et al 2000 BMP
Gong et al 2001 Wnt
Grottkau et al 2013 BMP, Wnt, Hedgehog
Heldin et al 1997 BMP
Hilton et al 2008 Notch
Hung et al 2015 ERK
Jacob et al 2006 FGF
Kadesch 2004 Notch
Kokabu et al 2012 BMP
Kwan et al 2011 FGF
Levi et al 2010 BMP
Levi et al 2011 BMP
Li et al 2016 VEGF
Lin et al 2008 BMP
Liu et al 2002 FGF
Long et al 2013 Hedgehog
Lu et al 2012 BMP
Lu et al 2013 BMP
Marie 2003 FGF
Marie 2012 FGF
Mie et al 2000 BMP
Montero et al 2000 FGF
Nakamura et al 1997 Hedgehog
Ohbayashi et al 2002 FGF
Quarto et al 2006 FGF
Quarto et al 2008 FGF
Rice 2008 BMP, Wnt
Santos et al 2010 VEGF
Sarkar et al 2001 FGF
Schmuhl et al 2014 ERK
Spinella-Jaegle et al 2001 Hedgehog
St-Jacques et al 1999 Hedgehog
Stevens et al 2010 Wnt
Tu et al 2007 Wnt
Vanhatupa et al 2015 BMP
Westendorf et al 2004 Wnt
Wodarz et al 1998 Wnt
Yuasa et al 2002 Hedgehog
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704transcription factor osterix (OSX).30,31 Extracellular signaling path-
ways converge on these transcription factors to orchestrate and
regulate osteoblastogenesis. The pathways are bone morphogenic
protein (BMP), wingless-related integration site protein (Wnt),
Notch, Hedgehog, fibroblast growth factor (FGF), vascular endo-
thelial growth factor (VEGF), and extracellular regulated-signal
kinase (ERK) (Fig. 1). The same signaling pathways play a role in
the direction of putative adult stem cells to an osteoblastic lineage,
demonstrated by the bone markers alkaline phosphatase (ALP),
type I collagen, osteopontin (OPN), and osteocalcin (OCN),
as well as matrix mineralization,32 for the purpose of tissue engi-
neering.33,34
Bone Morphogenic Protein
The BMPs belong to the transcription growth factor beta super-
family.35,36 This group is perhaps the most well-known of the
cytokines involved in osteogenesis, and as such, the majority of
studies related to ASCs and bone formation has revolved around the
BMP pathway.
The BMPs operate through signaling mothers against decapen-
taplegic (Smad) 1 phosphorylation.35,37 The phosphorylated Smads
promote osteogenic differentiation by forming a complex with
Smad4.34 The BMPs also increase the transcription of RUNX2.38
Subtypes BMP2 and BMP4 are particularly important, governing
crucial steps of differentiation by managing the transition from
RUNX2- to OSX-positive cells.39–41 The ASCs increase bone
regeneration significantly when loaded onto a scaffold with
BMP2 or when transfected with the BMP2 gene.42–47 On the
contrary, BMP3 is thought to have a negative regulatory effect
on osteogenesis48 through interaction with the BMP receptor type II
to inhibit BMP2 and BMP4 signaling.49
Downregulation of the osteogenic inhibitor Noggin in ASCs
triggered more appreciable mandibular regeneration in rats, and this
effect became more pronounced when Noggin-/- ASCs were sup-
plemented with BMP2.50–52 Furthermore, tumor necrosis factor
alpha (TNF-a), a major inflammatory factor peaking after bone
fracture, promoted BMP2 establishment in human primary osteo-
blasts and inhibited osteogenic differentiation when the pathway
was contacted with Noggin.53 Preconditioning with TNF-a aug-
mented proliferation, mobilization, and osteogenic differentiation
of ASCs and upregulated BMP2, upon silencing of BMP2 by
siRNA.54rized reproduction of this article is prohibited.
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FIGURE 1. Schematic of osteogenic differentiation induced by adipose-derived
stem cells. ALP, alkaline phosphatase; ASC, adipose-derived stem cell; BMP,
bone morphogenic protein; ERK, extracellular regulated-signal kinase; FGF,
fibroblast growth factor; MSC, mesenchymal stem cell; OCN, osteocalcin; OPN,
osteopontin; OSX, osterix; RUNX2, runt-related family 2; VEGF, vascular
endothelial growth factor; Wnt, wingless-related integration site protein.
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The Wnt family consists of a large number of secreted glycol
proteins that are involved in embryonic development, tissue induc-
tion, and axis polarity.55,56 Wnt ligands bind to frizzled receptors at
the cell surface and to LRP5 and LRP6 coreceptors.34 LRP5 gain of
function results in increased bone mass,57 whereas mutations in the
gene cause osteoporosis-pseudoglioma syndrome.58
Canonical Wnt signaling results in stabilization and transloca-
tion of b-catenin to the nucleus, where it binds to T-cell factor/
lymphoid enhancer factor (TCF/Lef) transcription factors.38 b-
catenin-TCF/Lef complexes activate transcription of multiple
Wnt-responsive genes, including those implicated in proliferation,
osteoblast differentiation, and osteogenesis.59–61
Noncanonical Wnt10b is identified for its unique requirement
for maintenance of mesenchymal progenitor activity in adult bone
after it was distinguished as the only Wnt ligand linking to
mesenchymal progenitor function in humans and mice.62 Some
studies revealed that noncanonical Wnt signaling, namely that of
Wnt5a with Ror2 and RhoA as counterparts, plus N-cadherin-
mediated b-catenin signaling, are necessary for mechanically
induced osteogenesis.63 Furthermore, Wnt4 may have potentiality
in improving bone regeneration and repair of craniofacial defects.64
Wnt3a and Wnt7b, also of the noncanonical variety, signal through
G-proteins to activate phosphatidylinositol signaling and PKCd, the
latter of which is necessary for osteoblastogenesis.65
Notch
The Notch network is known to be part of an evolutionarily
conserved mechanism that balances proliferation and differentia-
tion of stem cells.66 Such action begins with the Jagged
Delta protein’s attachment to the receptor34 prior to cleavage by
g-secretase to release the Notch intracellular domain.67
Notch inhibition in the embryonic limb leads to increased bone
mass and a reciprocal decrease in bone marrow mesenchymal
progenitors, thereby suggesting Notch’s function in suppressing
osteogenic differentiation and maintaining a sizable progenitor
pool.68 Notch is thought to act by quelling RUNX2 transcriptional
activity by induction of the transcription factors HEY1 and HEYL,
which physically interact with RUNX2.69
The miR-34a was found to upregulate RUNX2 by inhibiting
retinoblastoma binding protein 2 via the NOTCH1/CYCLIN D1
coregulatory network.70 Another report, however, observed that
Notch-1 overexpression inhibited osteogenesis by interrupting
canonicalWnt signaling, but failed to do so with interrupted BMP.71
Hedgehog
Pattern arrangement of bone tissue is greatly influenced by
Hedgehog signaling, albeit little work on it has been executed.34
In particular, Indian Hedgehog (IHH) plays a decisive job in
endochondral development, as Ihh-/- mice lack osteoblasts within
the endochondral tissue, but not in intramembranous tissue.72
Without IHH, mesenchymal progenitors in the perichondrium of
the cartilaginous anlagen do not express Runx2 and hence fail to
undergo differentiation.73 The IHH receptor Smoothened (Smo) has
been deemed necessary to build trabecular bone.72
On the contrary to IHH, Sonic Hedgehog (Shh) induces ALP
expression74,75 and augments selectivity in the differentiation of
MSCs into the osteoblast lineage.76
Fibroblast Growth Factor
The FGF2, FGF9, FGF18, and their corresponding receptors,
FGFR1, FGFR2, and FGFR3, are all linked to skeletal development
of the long bones and calvarium.77,78 Embryos of genotype Fgf18-/-Copyright © 2019 Mutaz B. Habal, MD. Unautho
# 2019 Mutaz B. Habal, MDhad defects in osteoblast maturation despite normal Runx2 expres-
sion.79,80 In contrast, FGFR1 activity has a tendency to launch
osteogenic differentiation at an early stage, only to inhibit mineral-
ization capabilities in mature osteoblasts.81 Gain of function muta-
tions in FGFR1, FGFR2, and FGFR3 caused craniosynostosis,
while implantation of beads soaked with FGF2 and FGF4 around
sutures caused osteogenesis and later suture closure.82,83
FGF2 serves as the quintessential example of how FGF is
connected to bone formation.84 Although the promotion of bone
repair via ASC mediation had been previously reported in vivo,
FGF2 was additionally found to inhibit terminal osteogenic differ-
entiation by antagonizing the retinoic acid-mediated upregulation
of BMP receptor type IB.85–87 This paradox can be explained when
one considers the principal function of FGF2, to promote the
proliferation and expansion of osteoprogenitor cells to maximize
the osteoprogenitor pool for future differentiation.85 Still, other
discussions are rooted in the fact that FGF2 can activate different
signaling pathways, including ERK, PI3K, and PKC, of which stage
and context would resolve the proliferation-versus-differentiation
debate.84,88 Given the complexity of FGF, as well as other signaling
pathways, the ability to guide a specific one in the context of ASC-
based therapy for bone formation would be a sweeping step in
regenerative medicine.5
Vascular Endothelial Growth Factor
Neurovascularization and angiogenesis are paramount to proper
bone foundation.89 It has been exhibited that VEGFA had a more
potent effect in precipitating ASC-mediated calvarial regeneration
than either BMP2 or FGF2, through a combination of osteogenesis
and angiogenesis.90
Dimethyloxaloglycine was tested for a dose-dependent effect by
levels of RUNX2, OCN, and ALP expression, plus VEGF, which is
produced as a product of HIF-1a overexpression.91 The ASCs
expressing Runx2 in combination with a vascularized flap led to
more effective bone repair than either facet acting alone, VEGF and
collagen type I were indicators.92
Extracellular Signal-Regulated Kinase
Another pathway that deals with osteogenic differentiation is
ERK, which is sometimes referred to as mitogen-activating protein
kinase, and where platelet-derived growth factor (PDGF) comes
into play.93 In 1 study, in the presence of PDGF-BB, ASCs, not
BMSCs, heightened osteogenic differentiation by increasing Runx2
and OCN output.94
Other Pathways Involved in Osteogenic
Differentiation
Erythropoietin has been reported to give rise to osteogenesis by
inhibiting PPARg, while IGF1 does the same through TAZ, and
when joined, resulted in even higher levels of Runx2, OPN, OCN,
ALP, and matrix mineralization.95 The ASCs magnofected with
Bcl2, an inhibitor of apoptosis, prompted greater ALP, extracellular
matrix mineralization, and expression of Ocn, Opn, and Runx2 than
nucleofected cells.96 miR-135 was shown to positively regulate
osteogenic differentiation based on bone markers and extracellular
matrix decomposition through a potentially new miR135/Hoxa2/
Runx2 pathway.97 The role of the transcription factor dFosB has
been explored, and the results obtained pointed to increased bone
mass and decreased adipocyte origination upon overexpression.98,99
A final biomolecule that has been scrutinized is growth and
differentiation factor 5, which appears to be more effective than
BMP2 in inducing onset of osteogenic differentiation while simul-
taneously prompting vascularization through VEGF.99,100rized reproduction of this article is prohibited.
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Taken together, these limited numbers of studies have assisted in
mapping out the signaling pathways that ASCs go through to become
bone. Most work has looked at the function that the BMP course
fulfills, followed by those of Wnt, Notch, Hedgehog, FGF, VEGF,
and ERK. By differing scaffold type and culture medium, molecular
composition, mechanical stress, chemical amalgamation, or bioen-
gineering, the effectiveness of osteogenic differentiation can be
evaluated. Activity of ALP, emergence of collagen type I, expression
of OCN and OPN, and mineralization through calcium precipitation
were quantified in most cases to analyze potential.
It hasbecome increasingly clear thatwithproper control of outside
inputs, ASCsmake an excellent choice for bone tissue engineering in
clinical practice. The ideal mixture of favorable inducers is not as
straightforward, but the depth of research insists that multiple
manipulation strategies exist, as long as the stem cells are exposed
to at least one inducer of osteogenesis early on.Additionally, there is a
trend in combining inducers as to achieve optimal outcomes.
New methods are necessitated to not only reduce the culture
period and quantity of growth factors, but also to enhance the
efficiency of osteogenesis and thus bone regeneration. One approach
is delivery of cytokines incorporating these molecules into scaffolds
as basic as liposomes and microspheres.17 This makes the growth
factor retainable at the site of interest for an extended period while
maintaining its biologic activity. Engineered ASCs with gene trans-
fection by virus vectors have evolved to be an attractive option to
ameliorate bone repair, especially in large bone defects.34 As bone
formation by implantation of ASCs must be preceded by the in vitro
osteogenic differentiation of these cells, it is compulsory to design
procedures that ensure a well-characterized and consistent cell
population following the differentiation process.34
REFERENCES
1. Steiner C, Elixhauser A, Schnaier J. The healthcare cost and utilization
project: an overview. Eff Clin Pract 2002;5:143–151
2. Deev RV, Drobyshev AY, Bozo IY, et al. Ordinary and activated bone
grafts: applied classification and the main features. BioMed Res Int
2015;2015:365050
3. ChiapascoM, Casentini P, ZaniboniM. Bone augmentation procedures
in implant dentistry. Int J Oral Maxillofac Implants 2009;24:237–259
4. Kaing L, Grubor D, Chandu A. Assessment of bone grafts placed
within an oral and maxillofacial training programme for implant
rehabilitation. Aust Dent J 2011;56:406–411
5. Senarath-Yapa K, McArdle A, Renda A, et al. Adipose-derived stem
cells: a review of signaling networks governing cell fate and
regenerative potential in the context of craniofacial and long bone
skeletal repair. Int J Mol Sci 2014;15:9314–9330
6. Zech NH, Preisegger KH, Hollands P. Stem cell therapeutics–reality
versus hype and hope. J Assist Reprod Genet 2011;28:287–290
7. Johnstone B, Hering TM, Caplan AI, et al. In vitro chondrogenesis of
bone marrow-derived mesenchymal progenitor cells. Exp Cell Res
1998;238:265–272
8. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of
adult human mesenchymal stem cells. Science 1999;284:143–147
9. Jaiswal RK, Jaiswal N, Bruder SP, et al. Adult human mesenchymal
stem cell differentiation to the osteogenic or adipogenic lineage is
regulated by mitogen-activated protein kinase. J Biol Chem
2000;275:9645–9652
10. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human
adipose tissue: implications for cell-based therapies. Tissue Eng
2001;7:211–228
11. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of
multipotent stem cells. Mol Biol Cell 2002;13:4279–4295
12. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for
regenerative medicine. Circ Res 2007;100:1249–1260
13. Zuk PA. Tissue engineering craniofacial defects with adult stem cells?
Are we ready yet? Pediatr Res 2008;63:478–486Copyright © 2019 Mutaz B. Habal, MD. Unautho
70614. Guilak F, Estes BT, Diekman BO, et al. 2010 Nicolas Andry Award:
multipotent adult stem cells from adipose tissue for musculoskeletal
tissue engineering. Clin Orthop Relat Res 2010;468:2530–2540
15. Saulnier N, Puglisi MA, Lattanzi W, et al. Gene profiling of bone
marrow- and adipose tissue-derived stromal cells: a key role of
Kruppel-like factor 4 in cell fate regulation.Cytotherapy 2011;13:329–
340
16. Strem BM, Hicok KC, Zhu M, et al. Multipotential differentiation of
adipose tissue-derived stem cells. Keio J Med 2005;54:132–141
17. Basmanav FB, Kose GT, Hasirci V. Sequential growth factor delivery
from complexed microspheres for bone tissue engineering.
Biomaterials 2008;29:4195–4204
18. Jeon O, Song SJ, Yang HS, et al. Long-term delivery enhances in vivo
osteogenic efficacy of bone morphogenetic protein-2 compared to
short-term delivery. Biochem Biophys Res Commun 2008;369:774–
780
19. Zhang S, Doschak MR, Uludag H. Pharmacokinetics and bone
formation by BMP-2 entrapped in polyethylenimine-coated albumin
nanoparticles. Biomaterials 2009;30:5143–5155
20. Engler AJ, Sen S, Sweeney HL, et al. Matrix elasticity directs stem cell
lineage specification. Cell 2006;126:677–689
21. Comisar WA, Kazmers NH, Mooney DJ, et al. Engineering RGD
nanopatterned hydrogels to control preosteoblast behavior: a combined
computational and experimental approach. Biomaterials
2007;28:4409–4417
22. Dalby MJ, Gadegaard N, Tare R, et al. The control of human
mesenchymal cell differentiation using nanoscale symmetry and
disorder. Nat Mater 2007;6:997–1003
23. Hofmann S, Hagenmuller H, Koch AM, et al. Control of in vitro tissue-
engineered bone-like structures using human mesenchymal stem cells
and porous silk scaffolds. Biomaterials 2007;28:1152–1162
24. Lindroos B, Suuronen R, Miettinen S. The potential of adipose stem
cells in regenerative medicine. Stem Cell Rev 2011;7:269–291
25. Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfa1: a transcriptional
activator of osteoblast differentiation. Cell 1997;89:747–754
26. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for
cleidocranial dysplasia syndrome, is essential for osteoblast
differentiation and bone development. Cell 1997;89:765–771
27. Ducy P, Starbuck M, Priemel M, et al. A Cbfa1-dependent genetic
pathway controls bone formation beyond embryonic development.
Genes Dev 1999;13:1025–1036
28. Choi JY, Pratap J, Javed A, et al. Subnuclear targeting of Runx/Cbfa/
AML factors is essential for tissue-specific differentiation during
embryonic development. Proc Natl Acad Sci U S A 2001;98:8650–
8655
29. Li J, Zhao Q, Wang E, et al. Transplantation of Cbfa1-overexpressing
adipose stem cells together with vascularized periosteal flaps repair
segmental bone defects. J Surg Res 2012;176:e13–e20
30. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-
containing transcription factor osterix is required for osteoblast
differentiation and bone formation. Cell 2002;108:17–29
31. Zhou X, Zhang Z, Feng JQ, et al. Multiple functions of Osterix are
required for bone growth and homeostasis in postnatal mice. Proc Natl
Acad Sci U S A 2010;107:12919–12924
32. Hicok KC, Du Laney TV, Zhou YS, et al. Human adipose-derived adult
stem cells produce osteoid in vivo. Tissue Eng 2004;10:371–380
33. Levi B, Longaker MT. Concise review: adipose-derived stromal cells
for skeletal regenerative medicine. Stem Cells 2011;29:576–582
34. Grottkau BE, Lin Y. Osteogenesis of adipose-derived stem cells. Bone
Res 2013;1:133–145
35. Heldin CH, Miyazono Kten Dijke P. TGF-beta signalling from cell
membrane to nucleus through SMAD proteins. Nature 1997;390:465–
471
36. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth
Factors 2004;22:233–241
37. Gilboa L, Nohe A, Geissendorfer T, et al. Bone morphogenetic protein
receptor complexes on the surface of live cells: a new oligomerization
mode for serine/threonine kinase receptors. Mol Biol Cell
2000;11:1023–1035
38. Rice DP. Craniofacial sutures. Development, disease and treatment.
Preface Front Oral Biol 2008;12:xirized reproduction of this article is prohibited.
# 2019 Mutaz B. Habal, MD
The Journal of Craniofacial Surgery  Volume 30, Number 3, May 2019 Osteogenic Differentiation of ASCs39. Mie M, Ohgushi H, Yanagida Y, et al. Osteogenesis coordinated in
C3H10T1/2 cells by adipogenesis-dependent BMP-2 expression
system. Tissue Eng 2000;6:9–18
40. Bandyopadhyay A, Tsuji K, Cox K, et al. Genetic analysis of the roles
of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis.
PLoS Genet 2006;2:e216
41. Vanhatupa S, OjansivuM, Autio R, et al. Bone morphogenetic protein-
2 induces donor-dependent osteogenic and adipogenic differentiation
in human adipose stem cells. Stem Cells Transl Med 2015;4:1391–
1402
42. Dragoo JL, Choi JY, Lieberman JR, et al. Bone induction by BMP-2
transduced stem cells derived from human fat. J Orthop Res
2003;21:622–629
43. Cowan CM, Shi YY, Aalami OO, et al. Adipose-derived adult stromal
cells heal critical-size mouse calvarial defects. Nat Biotechnol
2004;22:560–567
44. Dragoo JL, Lieberman JR, Lee RS, et al. Tissue-engineered bone from
BMP-2-transduced stem cells derived from human fat. Plast Reconstr
Surg 2005;115:1665–1673
45. Lin Y, Tang W, Wu L, et al. Bone regeneration by BMP-2 enhanced
adipose stem cells loading on alginate gel. Histochem Cell Biol
2008;129:203–210
46. Levi B, James AW, Nelson ER, et al. Human adipose derived stromal
cells heal critical size mouse calvarial defects. PLoS One
2010;5:e11177
47. Levi B, Hyun JS, Nelson ER, et al. Nonintegrating knockdown and
customized scaffold design enhances human adipose-derived stem
cells in skeletal repair. Stem Cells 2011;29:2018–2029
48. Daluiski A, Engstrand T, Bahamonde ME, et al. Bone morphogenetic
protein-3 is a negative regulator of bone density. Nat Genet
2001;27:84–88
49. Kokabu S, Gamer L, Cox K, et al. BMP3 suppresses osteoblast
differentiation of bone marrow stromal cells via interaction with
Acvr2b. Mol Endocrinol 2012;26:87–94
50. Fan J, Park H, Tan S, et al. Enhanced osteogenesis of adipose derived
stem cells with Noggin suppression and delivery of BMP-2. PLoS One
2013;8:e72474
51. Fan J, Park H, Lee MK, et al. Adipose-derived stem cells and BMP-2
delivery in chitosan-based 3D constructs to enhance bone regeneration
in a rat mandibular defect model. Tissue Eng Part A 2014;20:2169–
2179
52. Fan J, Im CS, Guo M, et al. Enhanced osteogenesis of adipose-derived
stem cells by regulating bone morphogenetic protein signaling
antagonists and agonists. Stem Cells Transl Med 2016;5:539–551
53. Lu Z, Wang G, Dunstan CR, et al. Short-term exposure to tumor
necrosis factor-alpha enables human osteoblasts to direct adipose
tissue-derived mesenchymal stem cells into osteogenic differentiation.
Stem Cells Dev 2012;21:2420–2429
54. Lu Z,Wang G, Dunstan CR, et al. Activation and promotion of adipose
stem cells by tumour necrosis factor-alpha preconditioning for bone
regeneration. J Cell Physiol 2013;228:1737–1744
55. Cadigan KM, Nusse R. Wnt signaling: a common theme in animal
development. Genes Dev 1997;11:3286–3305
56. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development.
Annu Rev Cell Dev Biol 1998;14:59–88
57. Boyden LM, Mao J, Belsky J, et al. High bone density due to a
mutation in LDL-receptor-related protein 5. N Engl J Med
2002;346:1513–1521
58. Gong Y, Slee RB, Fukai N, et al. LDL receptor-related protein 5
(LRP5) affects bone accrual and eye development.Cell 2001;107:513–
523
59. Bergwitz C, Wendlandt T, Kispert A, et al. Wnts differentially regulate
colony growth and differentiation of chondrogenic rat calvaria cells.
Biochim Biophys Acta 2001;1538:129–140
60. Fischer L, Boland G, Tuan RS. Wnt signaling during BMP-2
stimulation of mesenchymal chondrogenesis. J Cell Biochem
2002;84:816–831
61. Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in
osteoblasts and bone diseases. Gene 2004;341:19–39
62. Stevens JR, Miranda-Carboni GA, Singer MA, et al. Wnt10b
deficiency results in age-dependent loss of bone mass and progressiveCopyright © 2019 Mutaz B. Habal, MD. Unautho
# 2019 Mutaz B. Habal, MDreduction of mesenchymal progenitor cells. J Bone Miner Res
2010;25:2138–2147
63. Arnsdorf EJ, Tummala P, Jacobs CR. Non-canonicalWnt signaling and
N-cadherin related beta-catenin signaling play a role in mechanically
induced osteogenic cell fate. PLoS One 2009;4:e5388
64. Chang J, Sonoyama W, Wang Z, et al. Noncanonical Wnt-4 signaling
enhances bone regeneration of mesenchymal stem cells in craniofacial
defects through activation of p38 MAPK. J Biol Chem
2007;282:30938–30948
65. Tu X, Joeng KS, Nakayama KI, et al. Noncanonical Wnt signaling
through G protein-linked PKCdelta activation promotes bone
formation. Dev Cell 2007;12:113–127
66. Kadesch T. Notch signaling: the demise of elegant simplicity. Curr
Opin Genet Dev 2004;14:506–512
67. Chillakuri CR, Sheppard D, Lea SM, et al. Notch receptor-ligand
binding and activation: insights from molecular studies. Semin Cell
Dev Biol 2012;23:421–428
68. Tu X, Chen J, Lim J, et al. Physiological notch signaling maintains
bone homeostasis via RBPjk and Hey upstream of NFATc1. PLoS
Genet 2012;8:e1002577
69. Hilton MJ, Tu X, Wu X, et al. Notch signaling maintains bone marrow
mesenchymal progenitors by suppressing osteoblast differentiation.
Nat Med 2008;14:306–314
70. Fan C, Jia L, Zheng Y, et al. MiR-34a promotes osteogenic
differentiation of human adipose-derived stem cells via the RBP2/
NOTCH1/CYCLIN D1 coregulatory network. Stem Cell Reports
2016;7:236–248
71. Deregowski V, Gazzerro E, Priest L, et al. Notch 1 overexpression
inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not
bone morphogenetic protein signaling. J Biol Chem 2006;281:6203–
6210
72. St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog
signaling regulates proliferation and differentiation of chondrocytes
and is essential for bone formation. Genes Dev 1999;13:2072–2086
73. Long F, Ornitz DM. Development of the endochondral skeleton. Cold
Spring Harb Perspect Biol 2013;5:a008334
74. Nakamura T, Aikawa T, Iwamoto-Enomoto M, et al. Induction of
osteogenic differentiation by hedgehog proteins. Biochem Biophys Res
Commun 1997;237:465–469
75. Yuasa T, Kataoka H, Kinto N, et al. Sonic hedgehog is involved in
osteoblast differentiation by cooperating with BMP-2. J Cell Physiol
2002;193:225–232
76. Spinella-Jaegle S, Rawadi G, Kawai S, et al. Sonic hedgehog increases
the commitment of pluripotent mesenchymal cells into the osteoblastic
lineage and abolishes adipocytic differentiation. J Cell Sci
2001;114:2085–2094
77. Montero A, Okada Y, Tomita M, et al. Disruption of the fibroblast
growth factor-2 gene results in decreased bone mass and bone
formation. J Clin Invest 2000;105:1085–1093
78. Eswarakumar VP, Monsonego-Ornan E, Pines M, et al. The IIIc
alternative of Fgfr2 is a positive regulator of bone formation.
Development 2002;129:3783–3793
79. Liu Z, Xu J, Colvin JS, et al. Coordination of chondrogenesis and
osteogenesis by fibroblast growth factor 18. Genes Dev 2002;16:859–
869
80. Ohbayashi N, Shibayama M, Kurotaki Y, et al. FGF18 is required for
normal cell proliferation and differentiation during osteogenesis and
chondrogenesis. Genes Dev 2002;16:870–879
81. Jacob AL, Smith C, Partanen J, et al. Fibroblast growth factor receptor
1 signaling in the osteo-chondrogenic cell lineage regulates sequential
steps of osteoblast maturation. Dev Biol 2006;296:315–328
82. Burke D, Wilkes D, Blundell TL, et al. Fibroblast growth factor
receptors: lessons from the genes. Trends Biochem Sci 1998;23:59–62
83. Sarkar S, Petiot A, Copp A, et al. FGF2 promotes skeletogenic
differentiation of cranial neural crest cells. Development
2001;128:2143–2152
84. Marie PJ. Fibroblast growth factor signaling controlling osteoblast
differentiation. Gene 2003;316:23–32
85. Quarto N, Longaker MT. FGF-2 inhibits osteogenesis in mouse
adipose tissue-derived stromal cells and sustains their proliferative and
osteogenic potential state. Tissue Eng 2006;12:1405–1418rized reproduction of this article is prohibited.
707
Asserson et al The Journal of Craniofacial Surgery  Volume 30, Number 3, May 201986. Quarto N, Wan DC, Longaker MT. Molecular mechanisms of FGF-2
inhibitory activity in the osteogenic context of mouse adipose-derived
stem cells (mASCs). Bone 2008;42:1040–1052
87. Kwan MD, Sellmyer MA, Quarto N, et al. Chemical control of FGF-2
release for promoting calvarial healing with adipose stem cells. J Biol
Chem 2011;286:11307–11313
88. Marie PJ. Fibroblast growth factor signaling controlling bone
formation: an update. Gene 2012;498:1–4
89. Santos MI, Reis RL. Vascularization in bone tissue engineering:
physiology, current strategies, major hurdles and future challenges.
Macromol Biosci 2010;10:12–27
90. Behr B, Sorkin M, Lehnhardt M, et al. A comparative analysis of the
osteogenic effects of BMP-2, FGF-2, and VEGFA in a calvarial defect
model. Tissue Eng Part A 2012;18:1079–1086
91. Ding H, Gao YS, Wang Y, et al. Dimethyloxaloylglycine increases the
bone healing capacity of adipose-derived stem cells by promoting
osteogenic differentiation and angiogenic potential. Stem Cells Dev
2014;23:990–1000
92. Li Q, Wang T, Zhang GF, et al. A comparative evaluation of the
mechanical properties of two calcium phosphate/collagen composite
materials and their osteogenic effects on adipose-derived stem cells.
Stem Cells Int 2016;2016:6409546
93. Schmuhl E, Ramer R, Salamon A, et al. Increase of mesenchymal stem
cell migration by cannabidiol via activation of p42/44 MAPK.
Biochem Pharmacol 2014;87:489–501Copyright © 2019 Mutaz B. Habal, MD. Unautho
70894. Hung BP, Hutton DL, Kozielski KL, et al. Platelet-derived growth
factor BB enhances osteogenesis of adipose-derived but not bone
marrow-derived mesenchymal stromal/stem cells. Stem Cells
2015;33:2773–2784
95. Zhou J, Wei F, Ma Y. Inhibiting PPARgamma by erythropoietin while
upregulating TAZ by IGF1 synergistically promote osteogenic
differentiation of mesenchymal stem cells. Biochem Biophys Res
Commun 2016;478:349–355
96. Brett E, Zielins ER, Luan A, et al. Magnetic nanoparticle-based
upregulation of B-cell lymphoma 2 enhances bone regeneration. Stem
Cells Transl Med 2017;6:151–160
97. Xie Q, Wang Z, Zhou H, et al. The role of miR-135-modified adipose-
derived mesenchymal stem cells in bone regeneration. Biomaterials
2016;75:279–294
98. Sabatakos G, Sims NA, Chen J, et al. Overexpression of DeltaFosB
transcription factor(s) increases bone formation and inhibits
adipogenesis. Nat Med 2000;6:985–990
99. Rada T, Reis RL, Gomes ME. Adipose tissue-derived stem cells and
their application in bone and cartilage tissue engineering. Tissue Eng
Part B Rev 2009;15:113–125
100. Lough DM, Chambers C, Germann G, et al. Regulation of ADSC
osteoinductive potential using notch pathway inhibition and gene
rescue: a potential on/off switch for clinical applications in bone
formation and reconstructive efforts. Plast Reconstr Surg
2016;138:642e–652erized reproduction of this article is prohibited.
# 2019 Mutaz B. Habal, MD
